HULC and digestive system neoplasm: Therefore, as a promising therapeutic target, HULC has the following advantages: 1) High tissue specificity: HULC is significantly upregulated in digestive system tumors and is expressed at a lower level in most normal tissues, minimizing potential off-target effects.